| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.046 | 0.3 |